Meiji Yasuda Asset Management CO Ltd. Biogen Inc. Transaction History
Meiji Yasuda Asset Management CO Ltd.
- $2.56 Billion
- Q4 2024
A detailed history of Meiji Yasuda Asset Management CO Ltd. transactions in Biogen Inc. stock. As of the latest transaction made, Meiji Yasuda Asset Management CO Ltd. holds 1,960 shares of BIIB stock, worth $228,320. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,960
Previous 2,132
8.07%
Holding current value
$228,320
Previous $413,000
27.6%
% of portfolio
0.01%
Previous 0.02%
Shares
28 transactions
Others Institutions Holding BIIB
# of Institutions
1,015Shares Held
127MCall Options Held
1.77MPut Options Held
2.34M-
Vanguard Group Inc Valley Forge, PA16.7MShares$1.95 Billion0.05% of portfolio
-
Primecap Management CO Pasadena, CA16MShares$1.87 Billion1.94% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$1.69 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.4MShares$862 Million0.05% of portfolio
-
Geode Capital Management, LLC Boston, MA3.7MShares$430 Million0.04% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $16.8B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...